AstraZeneca stock popped Friday after the drugmaker beat Wall Street’s first-quarter expectations on the back of strong sales for cancer-treating drugs. AstraZeneca also raised its guidance.
AstraZeneca Stock Jumps On Quarterly Beat, No Thanks To Its Covid Vaccine
2021-04-30T14:02:39-04:00April 30th, 2021|